nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA9—hematologic cancer	0.257	1	CbGaD
Dorzolamide—CA14—Imatinib—hematologic cancer	0.0376	0.0729	CbGbCtD
Dorzolamide—CA6—Imatinib—hematologic cancer	0.0357	0.0693	CbGbCtD
Dorzolamide—CA14—Nilotinib—hematologic cancer	0.0342	0.0663	CbGbCtD
Dorzolamide—CA6—Nilotinib—hematologic cancer	0.0325	0.0629	CbGbCtD
Dorzolamide—CA7—Imatinib—hematologic cancer	0.0312	0.0604	CbGbCtD
Dorzolamide—CA7—Nilotinib—hematologic cancer	0.0283	0.0549	CbGbCtD
Dorzolamide—CA9—Imatinib—hematologic cancer	0.0267	0.0518	CbGbCtD
Dorzolamide—CA12—Imatinib—hematologic cancer	0.0267	0.0518	CbGbCtD
Dorzolamide—CA1—Imatinib—hematologic cancer	0.025	0.0485	CbGbCtD
Dorzolamide—CA9—Nilotinib—hematologic cancer	0.0243	0.0471	CbGbCtD
Dorzolamide—CA12—Nilotinib—hematologic cancer	0.0243	0.0471	CbGbCtD
Dorzolamide—CA1—Nilotinib—hematologic cancer	0.0227	0.044	CbGbCtD
Dorzolamide—CA2—Imatinib—hematologic cancer	0.0216	0.0419	CbGbCtD
Dorzolamide—CA4—Nilotinib—hematologic cancer	0.0214	0.0414	CbGbCtD
Dorzolamide—CA2—Nilotinib—hematologic cancer	0.0196	0.0381	CbGbCtD
Dorzolamide—CYP2C9—Bexarotene—hematologic cancer	0.0085	0.0165	CbGbCtD
Dorzolamide—CYP2C9—Idarubicin—hematologic cancer	0.00705	0.0137	CbGbCtD
Dorzolamide—CYP2C9—Bortezomib—hematologic cancer	0.00521	0.0101	CbGbCtD
Dorzolamide—CYP3A4—Bexarotene—hematologic cancer	0.00494	0.00958	CbGbCtD
Dorzolamide—CYP3A4—Lomustine—hematologic cancer	0.0046	0.00891	CbGbCtD
Dorzolamide—CYP3A4—Busulfan—hematologic cancer	0.0046	0.00891	CbGbCtD
Dorzolamide—CYP2C9—Thalidomide—hematologic cancer	0.00454	0.0088	CbGbCtD
Dorzolamide—CYP2C9—Teniposide—hematologic cancer	0.00433	0.00839	CbGbCtD
Dorzolamide—CYP3A4—Thiotepa—hematologic cancer	0.0041	0.00794	CbGbCtD
Dorzolamide—CYP2C9—Ifosfamide—hematologic cancer	0.004	0.00774	CbGbCtD
Dorzolamide—CYP2C9—Imatinib—hematologic cancer	0.00382	0.0074	CbGbCtD
Dorzolamide—CYP2C9—Nilotinib—hematologic cancer	0.00347	0.00672	CbGbCtD
Dorzolamide—CYP3A4—Methoxsalen—hematologic cancer	0.00319	0.00617	CbGbCtD
Dorzolamide—CYP3A4—Bortezomib—hematologic cancer	0.00303	0.00587	CbGbCtD
Dorzolamide—CYP3A4—Daunorubicin—hematologic cancer	0.0029	0.00562	CbGbCtD
Dorzolamide—CYP3A4—Cytarabine—hematologic cancer	0.00256	0.00495	CbGbCtD
Dorzolamide—CYP3A4—Teniposide—hematologic cancer	0.00252	0.00488	CbGbCtD
Dorzolamide—CYP3A4—Ifosfamide—hematologic cancer	0.00232	0.0045	CbGbCtD
Dorzolamide—CYP3A4—Imatinib—hematologic cancer	0.00222	0.0043	CbGbCtD
Dorzolamide—Brinzolamide—CA9—hematologic cancer	0.00219	1	CrCbGaD
Dorzolamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00209	0.00405	CbGbCtD
Dorzolamide—CYP3A4—Nilotinib—hematologic cancer	0.00202	0.00391	CbGbCtD
Dorzolamide—CYP3A4—Vinorelbine—hematologic cancer	0.002	0.00388	CbGbCtD
Dorzolamide—CYP2C9—Cisplatin—hematologic cancer	0.00194	0.00377	CbGbCtD
Dorzolamide—CYP3A4—Triamcinolone—hematologic cancer	0.00183	0.00355	CbGbCtD
Dorzolamide—CYP3A4—Dasatinib—hematologic cancer	0.00178	0.00346	CbGbCtD
Dorzolamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00176	0.00341	CbGbCtD
Dorzolamide—CYP2C9—Dexamethasone—hematologic cancer	0.00157	0.00304	CbGbCtD
Dorzolamide—CYP3A4—Betamethasone—hematologic cancer	0.00157	0.00304	CbGbCtD
Dorzolamide—CYP3A4—Prednisolone—hematologic cancer	0.00155	0.003	CbGbCtD
Dorzolamide—CYP3A4—Prednisone—hematologic cancer	0.00146	0.00283	CbGbCtD
Dorzolamide—CYP3A4—Irinotecan—hematologic cancer	0.00139	0.00269	CbGbCtD
Dorzolamide—CYP3A4—Vinblastine—hematologic cancer	0.00123	0.00239	CbGbCtD
Dorzolamide—CYP3A4—Vincristine—hematologic cancer	0.00121	0.00235	CbGbCtD
Dorzolamide—CYP3A4—Etoposide—hematologic cancer	0.00111	0.00215	CbGbCtD
Dorzolamide—CYP3A4—Dexamethasone—hematologic cancer	0.000913	0.00177	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—hematologic cancer	0.000758	0.00147	CbGbCtD
Dorzolamide—CA5B—hematopoietic system—hematologic cancer	0.000684	0.072	CbGeAlD
Dorzolamide—CA1—hematopoietic system—hematologic cancer	0.000604	0.0636	CbGeAlD
Dorzolamide—CA9—testis—hematologic cancer	0.000565	0.0595	CbGeAlD
Dorzolamide—CA5B—gonad—hematologic cancer	0.00052	0.0548	CbGeAlD
Dorzolamide—CA5B—blood—hematologic cancer	0.000453	0.0477	CbGeAlD
Dorzolamide—CA12—lung—hematologic cancer	0.000443	0.0466	CbGeAlD
Dorzolamide—CA1—blood—hematologic cancer	0.0004	0.0421	CbGeAlD
Dorzolamide—CA5B—lung—hematologic cancer	0.000397	0.0418	CbGeAlD
Dorzolamide—CA2—hematopoietic system—hematologic cancer	0.000392	0.0412	CbGeAlD
Dorzolamide—CA1—bone marrow—hematologic cancer	0.000387	0.0408	CbGeAlD
Dorzolamide—CA5B—testis—hematologic cancer	0.000375	0.0395	CbGeAlD
Dorzolamide—CA1—lung—hematologic cancer	0.000351	0.0369	CbGeAlD
Dorzolamide—CYP2C9—hematopoietic system—hematologic cancer	0.000331	0.0349	CbGeAlD
Dorzolamide—CA4—blood—hematologic cancer	0.000313	0.0329	CbGeAlD
Dorzolamide—CA4—bone marrow—hematologic cancer	0.000303	0.0319	CbGeAlD
Dorzolamide—CA4—lung—hematologic cancer	0.000274	0.0289	CbGeAlD
Dorzolamide—CA5B—lymph node—hematologic cancer	0.000272	0.0286	CbGeAlD
Dorzolamide—CA2—blood—hematologic cancer	0.000259	0.0273	CbGeAlD
Dorzolamide—CA4—testis—hematologic cancer	0.000259	0.0272	CbGeAlD
Dorzolamide—CYP3A4—hematopoietic system—hematologic cancer	0.000253	0.0266	CbGeAlD
Dorzolamide—CA2—bone marrow—hematologic cancer	0.000251	0.0264	CbGeAlD
Dorzolamide—CA1—lymph node—hematologic cancer	0.00024	0.0253	CbGeAlD
Dorzolamide—CA2—lung—hematologic cancer	0.000227	0.0239	CbGeAlD
Dorzolamide—CYP2C9—blood—hematologic cancer	0.000219	0.0231	CbGeAlD
Dorzolamide—CA2—testis—hematologic cancer	0.000215	0.0226	CbGeAlD
Dorzolamide—CA4—lymph node—hematologic cancer	0.000188	0.0198	CbGeAlD
Dorzolamide—CYP3A4—blood—hematologic cancer	0.000167	0.0176	CbGeAlD
Dorzolamide—CA2—lymph node—hematologic cancer	0.000156	0.0164	CbGeAlD
Dorzolamide—Vomiting—Gemcitabine—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Dorzolamide—Insomnia—Betamethasone—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Dorzolamide—Insomnia—Dexamethasone—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Dorzolamide—Paraesthesia—Dexamethasone—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Paraesthesia—Betamethasone—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Discomfort—Prednisone—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Rash—Gemcitabine—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Dermatitis—Gemcitabine—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—hematologic cancer	2.08e-05	0.000124	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—hematologic cancer	2.08e-05	0.000124	CcSEcCtD
Dorzolamide—Headache—Gemcitabine—hematologic cancer	2.08e-05	0.000124	CcSEcCtD
Dorzolamide—Nausea—Vincristine—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Dorzolamide—Hypersensitivity—Prednisolone—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Dorzolamide—Dyspepsia—Dexamethasone—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Dorzolamide—Dyspepsia—Betamethasone—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Dorzolamide—Urticaria—Triamcinolone—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—hematologic cancer	2.03e-05	0.000121	CcSEcCtD
Dorzolamide—Body temperature increased—Triamcinolone—hematologic cancer	2.03e-05	0.000121	CcSEcCtD
Dorzolamide—Anaphylactic shock—Prednisone—hematologic cancer	2.03e-05	0.000121	CcSEcCtD
Dorzolamide—Oedema—Prednisone—hematologic cancer	2.03e-05	0.000121	CcSEcCtD
Dorzolamide—Decreased appetite—Dexamethasone—hematologic cancer	2.03e-05	0.00012	CcSEcCtD
Dorzolamide—Decreased appetite—Betamethasone—hematologic cancer	2.03e-05	0.00012	CcSEcCtD
Dorzolamide—Nausea—Irinotecan—hematologic cancer	2.02e-05	0.00012	CcSEcCtD
Dorzolamide—Nausea—Mitoxantrone—hematologic cancer	2.02e-05	0.00012	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—hematologic cancer	2.01e-05	0.00012	CcSEcCtD
Dorzolamide—Fatigue—Dexamethasone—hematologic cancer	2.01e-05	0.000119	CcSEcCtD
Dorzolamide—Fatigue—Betamethasone—hematologic cancer	2.01e-05	0.000119	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—hematologic cancer	2e-05	0.000119	CcSEcCtD
Dorzolamide—Shock—Prednisone—hematologic cancer	2e-05	0.000119	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—hematologic cancer	2e-05	0.000119	CcSEcCtD
Dorzolamide—Pain—Betamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Dorzolamide—Pain—Dexamethasone—hematologic cancer	1.99e-05	0.000119	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—hematologic cancer	1.99e-05	0.000118	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—hematologic cancer	1.97e-05	0.000117	CcSEcCtD
Dorzolamide—Nausea—Gemcitabine—hematologic cancer	1.97e-05	0.000117	CcSEcCtD
Dorzolamide—Vomiting—Cisplatin—hematologic cancer	1.97e-05	0.000117	CcSEcCtD
Dorzolamide—Hyperhidrosis—Prednisone—hematologic cancer	1.96e-05	0.000117	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Dorzolamide—Rash—Cisplatin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Dorzolamide—Dermatitis—Cisplatin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—hematologic cancer	1.94e-05	0.000115	CcSEcCtD
Dorzolamide—Anorexia—Prednisone—hematologic cancer	1.94e-05	0.000115	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—hematologic cancer	1.93e-05	0.000115	CcSEcCtD
Dorzolamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Dorzolamide—Feeling abnormal—Betamethasone—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Dorzolamide—Tension—Epirubicin—hematologic cancer	1.91e-05	0.000114	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.91e-05	0.000113	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Betamethasone—hematologic cancer	1.91e-05	0.000113	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—hematologic cancer	1.91e-05	0.000113	CcSEcCtD
Dorzolamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—hematologic cancer	1.89e-05	0.000112	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—hematologic cancer	1.88e-05	0.000112	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—hematologic cancer	1.87e-05	0.000111	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—hematologic cancer	1.87e-05	0.000111	CcSEcCtD
Dorzolamide—Urticaria—Dexamethasone—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Dorzolamide—Urticaria—Betamethasone—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Dorzolamide—Dizziness—Prednisolone—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Dorzolamide—Asthenia—Triamcinolone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Dorzolamide—Body temperature increased—Dexamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Dorzolamide—Abdominal pain—Betamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Dorzolamide—Body temperature increased—Betamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Dorzolamide—Abdominal pain—Dexamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Dorzolamide—Nausea—Cisplatin—hematologic cancer	1.84e-05	0.000109	CcSEcCtD
Dorzolamide—Insomnia—Prednisone—hematologic cancer	1.84e-05	0.000109	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—hematologic cancer	1.83e-05	0.000109	CcSEcCtD
Dorzolamide—Paraesthesia—Prednisone—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Dorzolamide—Pruritus—Triamcinolone—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Dorzolamide—Cough—Methotrexate—hematologic cancer	1.81e-05	0.000108	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Dorzolamide—Dyspepsia—Prednisone—hematologic cancer	1.79e-05	0.000106	CcSEcCtD
Dorzolamide—Rash—Etoposide—hematologic cancer	1.79e-05	0.000106	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—hematologic cancer	1.78e-05	0.000106	CcSEcCtD
Dorzolamide—Headache—Etoposide—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—hematologic cancer	1.77e-05	0.000105	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—hematologic cancer	1.77e-05	0.000105	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—hematologic cancer	1.77e-05	0.000105	CcSEcCtD
Dorzolamide—Decreased appetite—Prednisone—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Dorzolamide—Rash—Prednisolone—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Dorzolamide—Dermatitis—Prednisolone—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Dorzolamide—Fatigue—Prednisone—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Dorzolamide—Headache—Prednisolone—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—hematologic cancer	1.74e-05	0.000104	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—hematologic cancer	1.74e-05	0.000104	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—hematologic cancer	1.72e-05	0.000102	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Dorzolamide—Dizziness—Triamcinolone—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Dorzolamide—Cough—Epirubicin—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Dorzolamide—Nausea—Etoposide—hematologic cancer	1.68e-05	0.0001	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—hematologic cancer	1.68e-05	9.99e-05	CcSEcCtD
Dorzolamide—Feeling abnormal—Prednisone—hematologic cancer	1.67e-05	9.95e-05	CcSEcCtD
Dorzolamide—Asthenia—Dexamethasone—hematologic cancer	1.67e-05	9.94e-05	CcSEcCtD
Dorzolamide—Asthenia—Betamethasone—hematologic cancer	1.67e-05	9.94e-05	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Prednisone—hematologic cancer	1.66e-05	9.87e-05	CcSEcCtD
Dorzolamide—Nausea—Prednisolone—hematologic cancer	1.66e-05	9.87e-05	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—hematologic cancer	1.66e-05	9.85e-05	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—hematologic cancer	1.66e-05	9.85e-05	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—hematologic cancer	1.65e-05	9.81e-05	CcSEcCtD
Dorzolamide—Pruritus—Dexamethasone—hematologic cancer	1.65e-05	9.81e-05	CcSEcCtD
Dorzolamide—Pruritus—Betamethasone—hematologic cancer	1.65e-05	9.81e-05	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—hematologic cancer	1.64e-05	9.75e-05	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—hematologic cancer	1.64e-05	9.73e-05	CcSEcCtD
Dorzolamide—Vomiting—Triamcinolone—hematologic cancer	1.63e-05	9.71e-05	CcSEcCtD
Dorzolamide—Rash—Triamcinolone—hematologic cancer	1.62e-05	9.63e-05	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—hematologic cancer	1.62e-05	9.63e-05	CcSEcCtD
Dorzolamide—Dermatitis—Triamcinolone—hematologic cancer	1.62e-05	9.62e-05	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—hematologic cancer	1.62e-05	9.62e-05	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—hematologic cancer	1.62e-05	9.62e-05	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—hematologic cancer	1.61e-05	9.6e-05	CcSEcCtD
Dorzolamide—Urticaria—Prednisone—hematologic cancer	1.61e-05	9.59e-05	CcSEcCtD
Dorzolamide—Headache—Triamcinolone—hematologic cancer	1.61e-05	9.57e-05	CcSEcCtD
Dorzolamide—Abdominal pain—Prednisone—hematologic cancer	1.6e-05	9.54e-05	CcSEcCtD
Dorzolamide—Body temperature increased—Prednisone—hematologic cancer	1.6e-05	9.54e-05	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—hematologic cancer	1.6e-05	9.52e-05	CcSEcCtD
Dorzolamide—Diarrhoea—Dexamethasone—hematologic cancer	1.59e-05	9.48e-05	CcSEcCtD
Dorzolamide—Diarrhoea—Betamethasone—hematologic cancer	1.59e-05	9.48e-05	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—hematologic cancer	1.59e-05	9.46e-05	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—hematologic cancer	1.59e-05	9.44e-05	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—hematologic cancer	1.59e-05	9.44e-05	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—hematologic cancer	1.59e-05	9.43e-05	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—hematologic cancer	1.58e-05	9.41e-05	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—hematologic cancer	1.57e-05	9.34e-05	CcSEcCtD
Dorzolamide—Shock—Epirubicin—hematologic cancer	1.56e-05	9.29e-05	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—hematologic cancer	1.55e-05	9.24e-05	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.55e-05	9.19e-05	CcSEcCtD
Dorzolamide—Dizziness—Betamethasone—hematologic cancer	1.54e-05	9.17e-05	CcSEcCtD
Dorzolamide—Dizziness—Dexamethasone—hematologic cancer	1.54e-05	9.17e-05	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—hematologic cancer	1.53e-05	9.13e-05	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—hematologic cancer	1.53e-05	9.12e-05	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—hematologic cancer	1.53e-05	9.11e-05	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—hematologic cancer	1.53e-05	9.11e-05	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—hematologic cancer	1.53e-05	9.08e-05	CcSEcCtD
Dorzolamide—Nausea—Triamcinolone—hematologic cancer	1.53e-05	9.07e-05	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—hematologic cancer	1.52e-05	9.06e-05	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—hematologic cancer	1.51e-05	9e-05	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—hematologic cancer	1.51e-05	9e-05	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—hematologic cancer	1.51e-05	8.99e-05	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—hematologic cancer	1.51e-05	8.97e-05	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—hematologic cancer	1.5e-05	8.91e-05	CcSEcCtD
Dorzolamide—Hypersensitivity—Prednisone—hematologic cancer	1.5e-05	8.89e-05	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—hematologic cancer	1.49e-05	8.88e-05	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—hematologic cancer	1.48e-05	8.82e-05	CcSEcCtD
Dorzolamide—Vomiting—Betamethasone—hematologic cancer	1.48e-05	8.81e-05	CcSEcCtD
Dorzolamide—Vomiting—Dexamethasone—hematologic cancer	1.48e-05	8.81e-05	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—hematologic cancer	1.48e-05	8.81e-05	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—hematologic cancer	1.47e-05	8.77e-05	CcSEcCtD
Dorzolamide—Rash—Dexamethasone—hematologic cancer	1.47e-05	8.74e-05	CcSEcCtD
Dorzolamide—Rash—Betamethasone—hematologic cancer	1.47e-05	8.74e-05	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—hematologic cancer	1.47e-05	8.74e-05	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—hematologic cancer	1.47e-05	8.74e-05	CcSEcCtD
Dorzolamide—Dermatitis—Dexamethasone—hematologic cancer	1.47e-05	8.73e-05	CcSEcCtD
Dorzolamide—Dermatitis—Betamethasone—hematologic cancer	1.47e-05	8.73e-05	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—hematologic cancer	1.46e-05	8.7e-05	CcSEcCtD
Dorzolamide—Headache—Betamethasone—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Dorzolamide—Headache—Dexamethasone—hematologic cancer	1.46e-05	8.68e-05	CcSEcCtD
Dorzolamide—Asthenia—Prednisone—hematologic cancer	1.46e-05	8.66e-05	CcSEcCtD
Dorzolamide—Pain—Methotrexate—hematologic cancer	1.45e-05	8.63e-05	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.45e-05	8.6e-05	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—hematologic cancer	1.45e-05	8.59e-05	CcSEcCtD
Dorzolamide—Pruritus—Prednisone—hematologic cancer	1.44e-05	8.54e-05	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—hematologic cancer	1.44e-05	8.54e-05	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—hematologic cancer	1.43e-05	8.48e-05	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—hematologic cancer	1.42e-05	8.44e-05	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—hematologic cancer	1.42e-05	8.42e-05	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—hematologic cancer	1.41e-05	8.39e-05	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—hematologic cancer	1.4e-05	8.33e-05	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—hematologic cancer	1.4e-05	8.31e-05	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—hematologic cancer	1.4e-05	8.31e-05	CcSEcCtD
Dorzolamide—Diarrhoea—Prednisone—hematologic cancer	1.39e-05	8.26e-05	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—hematologic cancer	1.39e-05	8.25e-05	CcSEcCtD
Dorzolamide—Nausea—Betamethasone—hematologic cancer	1.38e-05	8.23e-05	CcSEcCtD
Dorzolamide—Nausea—Dexamethasone—hematologic cancer	1.38e-05	8.23e-05	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—hematologic cancer	1.38e-05	8.21e-05	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—hematologic cancer	1.37e-05	8.16e-05	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—hematologic cancer	1.37e-05	8.14e-05	CcSEcCtD
Dorzolamide—Pain—Epirubicin—hematologic cancer	1.36e-05	8.07e-05	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—hematologic cancer	1.35e-05	8.01e-05	CcSEcCtD
Dorzolamide—Dizziness—Prednisone—hematologic cancer	1.34e-05	7.98e-05	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—hematologic cancer	1.34e-05	7.97e-05	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—hematologic cancer	1.34e-05	7.97e-05	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.34e-05	7.96e-05	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—hematologic cancer	1.33e-05	7.9e-05	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—hematologic cancer	1.32e-05	7.84e-05	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—hematologic cancer	1.31e-05	7.79e-05	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—hematologic cancer	1.31e-05	7.78e-05	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—hematologic cancer	1.31e-05	7.77e-05	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—hematologic cancer	1.3e-05	7.72e-05	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—hematologic cancer	1.29e-05	7.69e-05	CcSEcCtD
Dorzolamide—Vomiting—Prednisone—hematologic cancer	1.29e-05	7.67e-05	CcSEcCtD
Dorzolamide—Rash—Prednisone—hematologic cancer	1.28e-05	7.61e-05	CcSEcCtD
Dorzolamide—Dermatitis—Prednisone—hematologic cancer	1.28e-05	7.6e-05	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—hematologic cancer	1.28e-05	7.59e-05	CcSEcCtD
Dorzolamide—Headache—Prednisone—hematologic cancer	1.27e-05	7.56e-05	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—hematologic cancer	1.27e-05	7.53e-05	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—hematologic cancer	1.26e-05	7.5e-05	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—hematologic cancer	1.26e-05	7.47e-05	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—hematologic cancer	1.26e-05	7.46e-05	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—hematologic cancer	1.26e-05	7.46e-05	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—hematologic cancer	1.25e-05	7.43e-05	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—hematologic cancer	1.22e-05	7.24e-05	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—hematologic cancer	1.21e-05	7.2e-05	CcSEcCtD
Dorzolamide—Nausea—Prednisone—hematologic cancer	1.21e-05	7.17e-05	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.2e-05	7.14e-05	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—hematologic cancer	1.2e-05	7.14e-05	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—hematologic cancer	1.17e-05	6.96e-05	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—hematologic cancer	1.17e-05	6.94e-05	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—hematologic cancer	1.16e-05	6.91e-05	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—hematologic cancer	1.16e-05	6.91e-05	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—hematologic cancer	1.16e-05	6.9e-05	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—hematologic cancer	1.14e-05	6.77e-05	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—hematologic cancer	1.12e-05	6.68e-05	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—hematologic cancer	1.12e-05	6.67e-05	CcSEcCtD
Dorzolamide—CA7—Metabolism—PIK3CG—hematologic cancer	1.09e-05	0.000232	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CG—hematologic cancer	1.09e-05	0.000232	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTP1—hematologic cancer	1.09e-05	0.000231	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NCOR1—hematologic cancer	1.09e-05	0.000231	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—hematologic cancer	1.09e-05	0.000231	CbGpPWpGaD
Dorzolamide—Diarrhoea—Epirubicin—hematologic cancer	1.09e-05	6.46e-05	CcSEcCtD
Dorzolamide—CA6—Metabolism—CREBBP—hematologic cancer	1.09e-05	0.00023	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CREBBP—hematologic cancer	1.09e-05	0.00023	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYCS—hematologic cancer	1.08e-05	0.00023	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Doxorubicin—hematologic cancer	1.08e-05	6.44e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.08e-05	0.00023	CbGpPWpGaD
Dorzolamide—Vomiting—Methotrexate—hematologic cancer	1.08e-05	6.41e-05	CcSEcCtD
Dorzolamide—CA9—Metabolism—HSP90AA1—hematologic cancer	1.08e-05	0.000229	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCB1—hematologic cancer	1.07e-05	0.000228	CbGpPWpGaD
Dorzolamide—Rash—Methotrexate—hematologic cancer	1.07e-05	6.36e-05	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—hematologic cancer	1.07e-05	6.35e-05	CcSEcCtD
Dorzolamide—Headache—Methotrexate—hematologic cancer	1.06e-05	6.32e-05	CcSEcCtD
Dorzolamide—CA14—Metabolism—PIK3CD—hematologic cancer	1.06e-05	0.000224	CbGpPWpGaD
Dorzolamide—Asthenia—Doxorubicin—hematologic cancer	1.05e-05	6.27e-05	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—hematologic cancer	1.05e-05	6.24e-05	CcSEcCtD
Dorzolamide—CA2—Metabolism—GSTM1—hematologic cancer	1.04e-05	0.000221	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NCOR1—hematologic cancer	1.04e-05	0.000221	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—hematologic cancer	1.04e-05	0.000221	CbGpPWpGaD
Dorzolamide—Pruritus—Doxorubicin—hematologic cancer	1.04e-05	6.18e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.03e-05	0.000219	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCB1—hematologic cancer	1.03e-05	0.000218	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CD—hematologic cancer	1.03e-05	0.000218	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CD—hematologic cancer	1.03e-05	0.000218	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.02e-05	0.000216	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—hematologic cancer	1.02e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—hematologic cancer	1.02e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CREBBP—hematologic cancer	1.01e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CREBBP—hematologic cancer	1.01e-05	0.000215	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CG—hematologic cancer	1.01e-05	0.000215	CbGpPWpGaD
Dorzolamide—Vomiting—Epirubicin—hematologic cancer	1.01e-05	6e-05	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—hematologic cancer	1.01e-05	5.99e-05	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—hematologic cancer	1.01e-05	5.98e-05	CcSEcCtD
Dorzolamide—Rash—Epirubicin—hematologic cancer	1e-05	5.95e-05	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—hematologic cancer	1e-05	5.95e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism—SMPD3—hematologic cancer	1e-05	0.000212	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—hematologic cancer	9.99e-06	0.000212	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NCOR1—hematologic cancer	9.99e-06	0.000212	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	9.98e-06	0.000212	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3R1—hematologic cancer	9.97e-06	0.000211	CbGpPWpGaD
Dorzolamide—Headache—Epirubicin—hematologic cancer	9.95e-06	5.91e-05	CcSEcCtD
Dorzolamide—CA5A—Metabolism—PIK3R1—hematologic cancer	9.72e-06	0.000206	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3R1—hematologic cancer	9.72e-06	0.000206	CbGpPWpGaD
Dorzolamide—Dizziness—Doxorubicin—hematologic cancer	9.71e-06	5.78e-05	CcSEcCtD
Dorzolamide—CA4—Metabolism—MTHFR—hematologic cancer	9.61e-06	0.000204	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CD—hematologic cancer	9.6e-06	0.000204	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CD—hematologic cancer	9.6e-06	0.000204	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTP1—hematologic cancer	9.56e-06	0.000203	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—hematologic cancer	9.48e-06	0.000201	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—hematologic cancer	9.48e-06	0.000201	CbGpPWpGaD
Dorzolamide—Nausea—Epirubicin—hematologic cancer	9.43e-06	5.61e-05	CcSEcCtD
Dorzolamide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	9.41e-06	0.0002	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CREBBP—hematologic cancer	9.38e-06	0.000199	CbGpPWpGaD
Dorzolamide—Vomiting—Doxorubicin—hematologic cancer	9.34e-06	5.55e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.32e-06	0.000198	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	9.28e-06	0.000197	CbGpPWpGaD
Dorzolamide—Rash—Doxorubicin—hematologic cancer	9.26e-06	5.51e-05	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—hematologic cancer	9.25e-06	5.5e-05	CcSEcCtD
Dorzolamide—CA2—Metabolism—MTHFR—hematologic cancer	9.21e-06	0.000195	CbGpPWpGaD
Dorzolamide—Headache—Doxorubicin—hematologic cancer	9.2e-06	5.47e-05	CcSEcCtD
Dorzolamide—CA14—Metabolism—PIK3CB—hematologic cancer	9.2e-06	0.000195	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.09e-06	0.000193	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3R1—hematologic cancer	9.07e-06	0.000192	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3R1—hematologic cancer	9.07e-06	0.000192	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCB1—hematologic cancer	9.05e-06	0.000192	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CB—hematologic cancer	8.97e-06	0.00019	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CB—hematologic cancer	8.97e-06	0.00019	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CD—hematologic cancer	8.9e-06	0.000189	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—hematologic cancer	8.83e-06	0.000187	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NCOR1—hematologic cancer	8.78e-06	0.000186	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—hematologic cancer	8.78e-06	0.000186	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—hematologic cancer	8.78e-06	0.000186	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—B3GAT1—hematologic cancer	8.74e-06	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—DCK—hematologic cancer	8.74e-06	0.000185	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ASNS—hematologic cancer	8.74e-06	0.000185	CbGpPWpGaD
Dorzolamide—Nausea—Doxorubicin—hematologic cancer	8.73e-06	5.19e-05	CcSEcCtD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	8.65e-06	0.000183	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.54e-06	0.000181	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	8.53e-06	0.000181	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3R1—hematologic cancer	8.4e-06	0.000178	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CB—hematologic cancer	8.37e-06	0.000178	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CB—hematologic cancer	8.37e-06	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HDC—hematologic cancer	8.29e-06	0.000176	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CG—hematologic cancer	8.07e-06	0.000171	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTEN—hematologic cancer	7.95e-06	0.000169	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—hematologic cancer	7.76e-06	0.000165	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CB—hematologic cancer	7.76e-06	0.000165	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTEN—hematologic cancer	7.75e-06	0.000164	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTEN—hematologic cancer	7.75e-06	0.000164	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CG—hematologic cancer	7.74e-06	0.000164	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.73e-06	0.000164	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—EP300—hematologic cancer	7.58e-06	0.000161	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CDA—hematologic cancer	7.58e-06	0.000161	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CREBBP—hematologic cancer	7.48e-06	0.000159	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CG—hematologic cancer	7.42e-06	0.000157	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—EP300—hematologic cancer	7.39e-06	0.000157	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—EP300—hematologic cancer	7.39e-06	0.000157	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PC—hematologic cancer	7.29e-06	0.000155	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTEN—hematologic cancer	7.23e-06	0.000153	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTEN—hematologic cancer	7.23e-06	0.000153	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GMPS—hematologic cancer	7.21e-06	0.000153	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PHYH—hematologic cancer	7.21e-06	0.000153	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FTCD—hematologic cancer	7.21e-06	0.000153	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CREBBP—hematologic cancer	7.17e-06	0.000152	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CD—hematologic cancer	7.1e-06	0.000151	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GBA—hematologic cancer	7.05e-06	0.000149	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	7.05e-06	0.000149	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—hematologic cancer	7e-06	0.000149	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—EP300—hematologic cancer	6.9e-06	0.000146	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—EP300—hematologic cancer	6.9e-06	0.000146	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CREBBP—hematologic cancer	6.88e-06	0.000146	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CD—hematologic cancer	6.8e-06	0.000144	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—hematologic cancer	6.72e-06	0.000142	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTEN—hematologic cancer	6.7e-06	0.000142	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3R1—hematologic cancer	6.7e-06	0.000142	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	6.59e-06	0.00014	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—hematologic cancer	6.52e-06	0.000138	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CD—hematologic cancer	6.52e-06	0.000138	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTAP—hematologic cancer	6.44e-06	0.000137	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—hematologic cancer	6.44e-06	0.000137	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3R1—hematologic cancer	6.42e-06	0.000136	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—EP300—hematologic cancer	6.39e-06	0.000136	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CB—hematologic cancer	6.18e-06	0.000131	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3R1—hematologic cancer	6.16e-06	0.000131	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CREBBP—hematologic cancer	6.05e-06	0.000128	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CB—hematologic cancer	5.93e-06	0.000126	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	5.76e-06	0.000122	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DCK—hematologic cancer	5.76e-06	0.000122	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ASNS—hematologic cancer	5.76e-06	0.000122	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FHL2—hematologic cancer	5.74e-06	0.000122	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CD—hematologic cancer	5.73e-06	0.000122	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CB—hematologic cancer	5.69e-06	0.000121	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—hematologic cancer	5.66e-06	0.00012	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AGRN—hematologic cancer	5.63e-06	0.000119	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—hematologic cancer	5.61e-06	0.000119	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—hematologic cancer	5.47e-06	0.000116	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—hematologic cancer	5.47e-06	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HDC—hematologic cancer	5.46e-06	0.000116	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3R1—hematologic cancer	5.41e-06	0.000115	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTEN—hematologic cancer	5.34e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMMR—hematologic cancer	5.34e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—IDH2—hematologic cancer	5.34e-06	0.000113	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTEN—hematologic cancer	5.12e-06	0.000109	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—hematologic cancer	5.1e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—hematologic cancer	5.1e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—EP300—hematologic cancer	5.1e-06	0.000108	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.03e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ARNTL—hematologic cancer	5.02e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CB—hematologic cancer	5e-06	0.000106	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CDA—hematologic cancer	5e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTEN—hematologic cancer	4.91e-06	0.000104	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—EP300—hematologic cancer	4.89e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA9—hematologic cancer	4.88e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACP5—hematologic cancer	4.88e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOR2—hematologic cancer	4.82e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PC—hematologic cancer	4.81e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—hematologic cancer	4.73e-06	0.0001	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—EP300—hematologic cancer	4.68e-06	9.94e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GBA—hematologic cancer	4.65e-06	9.85e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.65e-06	9.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—IDH1—hematologic cancer	4.59e-06	9.74e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—hematologic cancer	4.58e-06	9.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.54e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TXN—hematologic cancer	4.54e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.54e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—hematologic cancer	4.47e-06	9.47e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—hematologic cancer	4.47e-06	9.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.44e-06	9.42e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTEN—hematologic cancer	4.32e-06	9.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.27e-06	9.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTAP—hematologic cancer	4.25e-06	9.01e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—hematologic cancer	4.17e-06	8.84e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—hematologic cancer	4.17e-06	8.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.15e-06	8.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.15e-06	8.81e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—EP300—hematologic cancer	4.12e-06	8.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.05e-06	8.58e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NUP98—hematologic cancer	3.92e-06	8.31e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—hematologic cancer	3.86e-06	8.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.8e-06	8.07e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.8e-06	8.07e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FHL2—hematologic cancer	3.79e-06	8.03e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NUP214—hematologic cancer	3.78e-06	8.01e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—hematologic cancer	3.77e-06	8e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.74e-06	7.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AGRN—hematologic cancer	3.71e-06	7.88e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTR—hematologic cancer	3.7e-06	7.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.7e-06	7.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENO2—hematologic cancer	3.63e-06	7.7e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—hematologic cancer	3.61e-06	7.67e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—IDH2—hematologic cancer	3.52e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMMR—hematologic cancer	3.52e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.52e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.47e-06	7.35e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—hematologic cancer	3.47e-06	7.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SDC1—hematologic cancer	3.44e-06	7.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.31e-06	7.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.29e-06	6.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.24e-06	6.88e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA9—hematologic cancer	3.22e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACP5—hematologic cancer	3.22e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.18e-06	6.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.1e-06	6.58e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—hematologic cancer	3.08e-06	6.53e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—hematologic cancer	3.05e-06	6.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—IDH1—hematologic cancer	3.03e-06	6.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TXN—hematologic cancer	2.99e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.99e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.99e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—hematologic cancer	2.95e-06	6.26e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.93e-06	6.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CD44—hematologic cancer	2.93e-06	6.2e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NQO1—hematologic cancer	2.93e-06	6.2e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.86e-06	6.08e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—hematologic cancer	2.83e-06	6e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.82e-06	5.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYCS—hematologic cancer	2.77e-06	5.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.75e-06	5.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.74e-06	5.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.74e-06	5.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.67e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.58e-06	5.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.51e-06	5.32e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.51e-06	5.32e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NUP214—hematologic cancer	2.49e-06	5.28e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—hematologic cancer	2.49e-06	5.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.48e-06	5.25e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.44e-06	5.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.44e-06	5.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.44e-06	5.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.39e-06	5.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.36e-06	5.01e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.32e-06	4.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.31e-06	4.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.27e-06	4.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.24e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.24e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.98e-06	4.2e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.93e-06	4.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CD44—hematologic cancer	1.93e-06	4.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.83e-06	3.87e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.81e-06	3.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.75e-06	3.7e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.66e-06	3.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.61e-06	3.41e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.54e-06	3.27e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.52e-06	3.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.48e-06	3.14e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.48e-06	3.14e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.46e-06	3.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—hematologic cancer	1.44e-06	3.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.38e-06	2.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.31e-06	2.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.28e-06	2.71e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTEN—hematologic cancer	1.1e-06	2.34e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.1e-06	2.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—EP300—hematologic cancer	1.05e-06	2.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.02e-06	2.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.65e-07	2.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—hematologic cancer	9.53e-07	2.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.11e-07	1.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.41e-07	1.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.78e-07	1.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTEN—hematologic cancer	7.27e-07	1.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—EP300—hematologic cancer	6.93e-07	1.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—hematologic cancer	6.35e-07	1.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.13e-07	1.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—hematologic cancer	4.19e-07	8.89e-06	CbGpPWpGaD
